Results 341 to 350 of about 2,069,003 (398)
ESC Heart Failure, EarlyView.Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann +5 more
wiley +1 more source
The Pulmonary Insufficiency and the Liver Circulation
, 1964 Shizuo Katagiri, Rokuichi Iga
openalex +2 more sources
ESC Heart Failure, EarlyView.Flow chart illustrates the analysed patients as well as main baseline characteristics and outcomes comparing DanGer Shock‐like versus DanGer Shock‐unlike patients. The composite safety endpoint comprises severe bleeding, limb ischaemia, haemolysis, device failure, and worsening of aortic regurgitation. CS indicates cardiogenic shock.
Norman Mangner +10 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Inter‐atrial shunt device therapy has shown mixed results in clinical trials, with clinical ‘non‐responders’ typically showing features of more advanced heart failure. We aimed to analyse the haemodynamic and clinical response of a novel left atrial to coronary sinus (LA‐CS) shunt device in patients with higher natriuretic peptide (NP ...
Ryan J. Tedford +9 more
wiley +1 more source
ESC Heart Failure, EarlyView.Routine data analysis showing a better outcome regarding mortality and readmission in HF patients when being prescribed the current four‐drug treatment (vs. the outdated two‐drug therapy) 91–365 days after index hospital stay. Abstract Aims The 2021 European heart failure (HF) guidelines recommend the combination of four drugs as a standard therapy ...
Martin Möckel +9 more
wiley +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
ESC Heart Failure, EarlyView.Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna +4 more
wiley +1 more source
ESC Heart Failure, EarlyView.Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem +13 more
wiley +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala +1 more
wiley +1 more source
BUN‐to‐ALB ratio as an effective predictor of 30 day mortality in ADHF patients in eastern China
ESC Heart Failure, EarlyView.Abstract Aims The blood urea nitrogen‐to‐albumin ratio (BAR) is considered a potential indicator for assessing the poor prognosis of heart failure (HF). However, its prognostic value for Chinese patients with acute decompensated HF (ADHF) remains unclear.
Xin Huang +8 more
wiley +1 more source